Pharmacokinetics of fosinopril in Chinese patients with mild to moderate congestive heart failure

Clinical Drug Investigation

Volumn 16, Issue 5, 1998, Pages 377-385

  Chen, Jyh Hong ^a   Ding, Philip ^b   Chang, Mau Song ^c   Chang, Audrey ^d   Delaney, Carol L ^d   Morgenthien, Elizabeth A ^d   MacAskill, Maynard ^d   DeSilva, Jacqueline ^d   Liao, Wei Chi ^d  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; FOSINOPRILAT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHINESE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG URINE LEVEL; EDEMA; ENZYME INHIBITION; FEMALE; HEART EJECTION FRACTION; HUMAN; KIDNEY CLEARANCE; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUTH ULCER; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; STUDY; SUDDEN DEATH; SYNCOPE;

EID: 0031729196     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199816050-00005     Document Type: Article

References (13)

1. Duchin KL. Clinical pharmacology of fosinopril. Drug Invest 1991; 3 Suppl. 14: 12-7
2. Shammas FV, Dickstein K. Clinical pharmacokinetics in heart failure: an updated review. Clin Pharmacokinet 1988; 15: 94-113
3. Cody RJ. Pharmacology of angiotensin-converting enzyme inhibitors as a guide to their use in congestive heart failure. Am J Cardiol 1990; 66: 7D-13D
4. Dickstein K, Till AE, Aarsland T, et al. The pharmacokinetics of enalapril in hospitalized patients with congestive heart failure. Br J Clin Pharmacol 1987; 23: 403-10
5. Till AE, Dickstein K, Aarsland T, et al. The pharmacokinetics of lisinopril in hospitalized patients with congestive heart failure. Br J Clin Pharmacol 1989; 27: 199-204
6. Ford NF, Natarajan C, Fulmor E, et al. Invasive pharmacodynamics of fosinopril in patients with congestive heart failure. J Clin Pharmacol 1995; 35: 785-93
7. Rohatgi PK, Ryan JW. Simple radioassay for measuring serum activity of angiotensin-converting enzyme in sarcoidosis. Chest 1980; 78: 69-76
8. Wang-Inverson D, Ivashkiv E, Jemal M, et al. Simultaneous determination of SQ 28,555 and SQ 27,519 in serum by HPLC combined with ionspray mass spectrometry. Proceedings of the 39th ASMS Conference on Mass Spectrometry and Allied Topics, Nashville, 1991 May 19-24; ASMS, Sante Fe, NM, USA 1991: 1249-50
9. Littell RC, Freund RJ, Spector PC. SAS® System for Linear Models. 3rd ed. Cary, NC: SAS Institute, Inc, 1991
10. Locke CS. An exact confidence interval from untransformed data for the ratio of two formulation means. J Pharmacokinet Biopharm 1984; 12: 649-55
11. Kostis JB, Garland WT, Delaney C, et al. Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure. Clin Pharmacol Ther 1995; 58: 660-5
12. Ding YA, Hu OY-P, Huang GM, et al. Single dose oral and intravenous pharmacokinetics and pharmacodynamics of fosinopril in healthy Chinese male volunteers [abstract]. Proceedings of the 4th International - 2nd Asian-Pacific Symposium on ACE inhibition and other inhibitors of the renin-angiotensin system; 1995 April 24-28: Beijing. Hong Kong: Gardiner-Caldwell, 110
13. Ding YA, Chu K-m, Hu OY-P, et al. Fosinopril: pharmacokinetics and pharmacodynamics in Chinese subjects. J Clin Pharmacol (submitted)